| Year |
Citation |
Score |
| 2024 |
Wang Z, Li W, Jiang Y, Park J, Gonzalez KM, Wu X, Zhang QY, Lu J. Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery. Nature Communications. 15: 2073. PMID 38453918 DOI: 10.1038/s41467-024-46331-7 |
0.33 |
|
| 2024 |
Wang Z, Li W, Jiang Y, Tran TB, Chung J, Kim M, Scott AJ, Lu J. Camptothesome-based combination nanotherapeutic regimen for improved colorectal cancer immunochemotherapy. Biomaterials. 306: 122477. PMID 38309054 DOI: 10.1016/j.biomaterials.2024.122477 |
0.454 |
|
| 2023 |
Wang Z, Li W, Jiang Y, Tran TB, Cordova LE, Chung J, Kim M, Wondrak G, Erdrich J, Lu J. Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy. Nature Communications. 14: 7235. PMID 37945606 DOI: 10.1038/s41467-023-43079-4 |
0.681 |
|
| 2023 |
Wang Z, Gonzalez KM, Cordova LE, Lu J. Nanotechnology-empowered therapeutics targeting neurodegenerative diseases. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. e1907. PMID 37248794 DOI: 10.1002/wnan.1907 |
0.632 |
|
| 2022 |
Wang Z, Cordova LE, Chalasani P, Lu J. Camptothesome Potentiates PD-L1 Immune Checkpoint Blockade for Improved Metastatic Triple-Negative Breast Cancer Immunochemotherapy. Molecular Pharmaceutics. 19: 4665-4674. PMID 36413426 DOI: 10.1021/acs.molpharmaceut.2c00701 |
0.696 |
|
| 2022 |
Wang Z, Li W, Park J, Gonzalez KM, Scott AJ, Lu J. Camptothesome elicits immunogenic cell death to boost colorectal cancer immune checkpoint blockade. Journal of Controlled Release : Official Journal of the Controlled Release Society. 349: 929-939. PMID 35926754 DOI: 10.1016/j.jconrel.2022.07.042 |
0.675 |
|
| 2021 |
Wang Z, Little N, Chen J, Lambesis KT, Le KT, Han W, Scott AJ, Lu J. Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy. Nature Nanotechnology. PMID 34385682 DOI: 10.1038/s41565-021-00950-z |
0.702 |
|
| 2020 |
Wang Z, Chen J, Little N, Lu J. Self-assembling Prodrug Nanotherapeutics for Synergistic Tumor Targeted Drug Delivery. Acta Biomaterialia. PMID 32454086 DOI: 10.1016/J.Actbio.2020.05.026 |
0.655 |
|
| 2018 |
Deng J, Peng M, Wang Z, Zhou S, Xiao D, Deng J, Yang X, Peng J, Yang X. Novel Application of Metformin Combined with Targeted Drugs on Anticancer Treatment. Cancer Science. PMID 30358009 DOI: 10.1111/cas.13849 |
0.311 |
|
| Show low-probability matches. |